Atinumab (Anti-RTN4 / NOGO)
Atinumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI). MW :137.82 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3051 |
| Sku # | A3051-1mg*5 |
| Pricing | 1mg*5, $1690.00 |